Schedule 13D ownership disclosure
Pulse Biosciences Inc
Common Stock, par value $0.001 per share · CUSIP: 74587B101
Event date: 2024-12-18
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Robert W. DugganReported CIK 0001055919
Shares: 48,792,335 · Class: 70.6%
- GENIUS 24C INC
Shares: 630,109 · Class: 0.9%
- Blazon Corporation
Shares: 450,189 · Class: 0.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-24-138214
- Form type
- SCHEDULE 13D/A
- Filer
- DUGGAN ROBERT W
- CIK
- CIK 1055919
- Filed
- Dec 19, 2024
- Reporting period
- Dec 18, 2024
- Description
- Schedule 13D beneficial ownership